Altrinsic Global Advisors LLC Biomarin Pharmaceutical Inc Transaction History

Altrinsic Global Advisors LLC

  • $2.15 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$80.14 - $106.07 $3.3 Million - $4.37 Million
-41,168 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$93.92 - $105.72 $1.41 Million - $1.59 Million
-15,000 Reduced 26.71%
41,168 $3.99 Million
Q4 2017

Feb 13, 2018
BUY
$80.76 - $95.13 $888,360 - $1.05 Million
11,000 Added 24.35%
56,168 $5.01 Million
Q3 2017

Nov 14, 2017
BUY
$80.6 - $94.95 $3.64 Million - $4.29 Million
45,168
45,168 $4.2 Million

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.5B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Altrinsic Global Advisors LLC Portfolio

Follow Altrinsic Global Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altrinsic Global Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email